| Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019 PD Burbelo, FX Riedo, C Morishima, S Rawlings, D Smith, S Das, ... The Journal of infectious diseases 222 (2), 206-213, 2020 | 343 | 2020 |
| Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data SS Kadri, C Rhee, JR Strich, MK Morales, S Hohmann, J Menchaca, ... Chest 151 (2), 278-285, 2017 | 242 | 2017 |
| Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to spike protein in COVID-19 patients PD Burbelo, FX Riedo, C Morishima, S Rawlings, D Smith, S Das, ... MedRxiv, 2020 | 182 | 2020 |
| Association between caseload surge and COVID-19 survival in 558 US hospitals, March to August 2020 SS Kadri, J Sun, A Lawandi, JR Strich, LM Busch, M Keller, A Babiker, ... Annals of Internal Medicine 174 (9), 1240-1251, 2021 | 161 | 2021 |
| Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors … SS Kadri, YL Lai, S Warner, JR Strich, A Babiker, EE Ricotta, ... The Lancet Infectious Diseases 21 (2), 241-251, 2021 | 152 | 2021 |
| Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure C Rhee, K Chiotos, SE Cosgrove, EL Heil, SS Kadri, AC Kalil, DN Gilbert, ... Clinical Infectious Diseases 72 (4), 541-552, 2021 | 132 | 2021 |
| CRISPR-Cas biology and its application to infectious diseases JR Strich, DS Chertow Journal of clinical microbiology 57 (4), 10.1128/jcm. 01307-18, 2019 | 103 | 2019 |
| Preventing transmission of multidrug-resistant pathogens in the intensive care unit JR Strich, TN Palmore Infectious Disease Clinics 31 (3), 535-550, 2017 | 103 | 2017 |
| Considerations for empiric antimicrobial therapy in sepsis and septic shock in an era of antimicrobial resistance JR Strich, EL Heil, H Masur The Journal of Infectious Diseases 222 (Supplement_2), S119-S131, 2020 | 92 | 2020 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 87 | 2022 |
| Invasive candidiasis species distribution and trends, United States, 2009–2017 EE Ricotta, YL Lai, A Babiker, JR Strich, SS Kadri, MS Lionakis, ... The Journal of infectious diseases 223 (7), 1295-1302, 2021 | 71 | 2021 |
| Fostamatinib inhibits neutrophils extracellular traps induced by COVID-19 patient plasma: a potential therapeutic JR Strich, MJ Ramos-Benitez, D Randazzo, SR Stein, A Babyak, ... The Journal of infectious diseases 223 (6), 981-984, 2021 | 69 | 2021 |
| Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre … A Babiker, X Li, YL Lai, JR Strich, S Warner, S Sarzynski, JP Dekker, ... The Lancet Infectious Diseases 21 (5), 697-710, 2021 | 65 | 2021 |
| Role of granulocyte transfusions in invasive fusariosis: systematic review and single‐center experience SS Kadri, KE Remy, JR Strich, J Gea‐Banacloche, SF Leitman Transfusion 55 (9), 2076-2085, 2015 | 54 | 2015 |
| External validation of difficult-to-treat resistance prevalence and mortality risk in gram-negative bloodstream infection using electronic health record data from 140 US hospitals SS Kadri, YL Lai, EE Ricotta, JR Strich, A Babiker, C Rhee, M Klompas, ... Open forum infectious diseases 6 (4), ofz110, 2019 | 48 | 2019 |
| Fostamatinib for the treatment of hospitalized adults with coronavirus disease 2019: a randomized trial JR Strich, X Tian, M Samour, CS King, O Shlobin, R Reger, J Cohen, ... Clinical Infectious Diseases 75 (1), e491-e498, 2022 | 42 | 2022 |
| Driving blind: instituting SEP-1 without high quality outcomes data J Wang, JR Strich, WN Applefeld, J Sun, X Cui, C Natanson, ... Journal of thoracic disease 12 (Suppl 1), S22, 2020 | 39 | 2020 |
| High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19 SH Ko, E Bayat Mokhtari, P Mudvari, S Stein, CD Stringham, D Wagner, ... PLoS Pathogens 17 (4), e1009431, 2021 | 36 | 2021 |
| Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study JR Strich, S Warner, YL Lai, CY Demirkale, JH Powers, RL Danner, ... The Lancet Infectious Diseases 20 (10), 1172-1181, 2020 | 34 | 2020 |
| Tracking colistin-treated patients to monitor the incidence and outcome of carbapenem-resistant gram-negative infections SS Kadri, SF Hohmann, EJ Orav, SL Bonne, MA Moffa, JG Timpone, ... Clinical infectious diseases 60 (1), 79-87, 2015 | 28 | 2015 |
